No abstract available
Keywords:
Cholestérol LDL; LDL cholesterol; LDL-Cholesterin; PCSK9 inhibitors; PCSK9-Inhibitoren; Statine; cardiovascular risk; inhibiteurs de la PCSK9; kardiovaskuläres Risiko; risque cardiovasculaire; statines; statins.
MeSH terms
-
Adult
-
Aged
-
Algorithms
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / diagnosis
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / prevention & control*
-
Dyslipidemias / blood
-
Dyslipidemias / diagnosis
-
Dyslipidemias / drug therapy*
-
Female
-
Guideline Adherence
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Hypercholesterolemia / blood
-
Hypercholesterolemia / diagnosis
-
Hypercholesterolemia / drug therapy
-
Male
-
Middle Aged
-
PCSK9 Inhibitors*
-
Risk
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
PCSK9 Inhibitors
-
PCSK9 protein, human